Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials (Review).
about
Decoding the usefulness of non-coding RNAs as breast cancer markersFrom bench to bedside: What do we know about hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cancer?Context Specific and Differential Gene Co-expression Networks via Bayesian BiclusteringTranscriptional regulation of mixed lineage kinase 3 by estrogen and its implication in ER-positive breast cancer pathogenesisAn Introspective Update on the Influence of miRNAs in Breast Carcinoma and Neuroblastoma ChemoresistanceRapid detection of genetic mutations in individual breast cancer patients by next-generation DNA sequencingTargeting glycolysis by 3-bromopyruvate improves tamoxifen cytotoxicity of breast cancer cell lines.Estrogen Receptor Expression Is Associated with DNA Repair Capacity in Breast Cancer.Human Epidermal Growth Factor Receptor 2 (HER2) Impedes MLK3 Kinase Activity to Support Breast Cancer Cell Survival.Expression Data Analysis for the Identification of Potential Biomarker of Pregnancy Associated Breast Cancer.MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1.HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR.Formal modeling and analysis of ER-α associated Biological Regulatory Network in breast cancer.Genomic regulation of invasion by STAT3 in triple negative breast cancer.Cooperative antitumor activities of carnosic acid and Trastuzumab in ERBB2+ breast cancer cells.Explorative visual analytics on interval-based genomic data and their metadata.Identification of glycerol-3-phosphate dehydrogenase 1 as a tumour suppressor in human breast cancer.A combined approach with gene-wise normalization improves the analysis of RNA-seq data in human breast cancer subtypes
P2860
Q28069370-47E57AD6-FF01-48CF-8A07-5CBD9F5B3B7FQ28084982-28A6B447-7873-41B3-8550-80E8902AC7B6Q28553187-E4C6265A-128C-45F9-AF58-53804291853EQ33779406-157B21F7-B308-4E27-B840-09AF2281A850Q34753903-668891A6-657B-4FFE-BB63-EFD5F8661038Q35142605-300BF95F-ED91-4D14-9399-91329DED285AQ35829696-13AC20C8-F7E1-4142-B02C-F2DE4C1748CBQ35975638-8BB3C1E8-6037-4AE3-B134-F140390AE75EQ36065138-1EEFF8A5-1FD8-46B0-A793-3702E40984E3Q36189018-C242F9A1-EC94-4A6A-B83B-7CF68FB026BEQ36343310-688A6D1D-0C54-4BDD-97D9-766696E368FFQ37169043-DAAA5917-DACB-4C92-8CE7-55106026A369Q37359952-435A62C3-679C-472F-B0E1-791709F1E62AQ37702690-D25040B8-AE3F-4850-99C0-C4EE5EF65AEDQ46216419-F1A1C99E-B974-4B4C-969A-E43CD36228A7Q47104264-C7BA9201-DE3B-44FF-ACB0-E566E2DAB7E9Q47127880-678565CC-4B33-4932-9FA3-B48EC89CDE9FQ58796166-C7A3A9BC-02D0-4949-9B68-63E89D09E1F7
P2860
Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials (Review).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Estrogen receptor-positive bre ...... erapeutic potentials (Review).
@en
Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials
@nl
type
label
Estrogen receptor-positive bre ...... erapeutic potentials (Review).
@en
Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials
@nl
prefLabel
Estrogen receptor-positive bre ...... erapeutic potentials (Review).
@en
Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials
@nl
P2093
P2860
P356
P1433
P1476
Estrogen receptor-positive bre ...... erapeutic potentials (Review).
@en
P2093
Hong Tao Man
Mei Hong Zhang
Shi Liang Ma
Xiao Dan Zhao
P2860
P356
10.3892/BR.2013.187
P577
2013-10-25T00:00:00Z